Orlando, FL (PRWEB) February 25, 2013
The prescription drug resource center DrugRisk.com is alerting patients taking the popular blood thinner Pradaxa of updated legal news information added to the site showing the federal court overseeing Pradaxa bleeding lawsuits has scheduled a new hearing for next month.
“DrugRisk’s mission is to improve the patient safety by providing the latest drug warnings, recalls, studies and litigation news. Patients informed of drug news can discuss side effect options with their doctor and decide if they need legal advice,“ explains DrugRisk representative Ryan Mayer.
The resource center contains information from health organizations showing experts have differing opinions about the safety of Pradaxa. The FDA recently updated an advisory to indicate the drug carries the same risks as warfarin.* However, the American College of Cardiology has warned Pradaxa can significantly increase the risk of bleeding complications compared to warfarin.**
DrugRisk has also obtained a report from the Institute for Safe Medication Practices ranking anticoagulants like Pradaxa among the highest risk outpatient drugs. In reviewing adverse event reports of hemorrhaging submitted to the FDA, the institute found bleeding from Pradaxa almost 5 times as likely to result in death than with warfarin.***
Due to the number of patients filing a Pradaxa lawsuit over bleeding side effects, the cases have been consolidated to a special federal court in Illinois, formally known as MDL No. 2385, IN RE: Pradaxa Product Liability Litigation, Southern District of Illinois.
Now, the judge presiding over the litigation, U.S. Chief District Judge David Herndon, has scheduled the latest status conference hearing for Pradaxa to take place on March 14, 2013.****
Anyone affected by internal bleeding after taking Pradaxa is urged to speak with a lawyer about their legal options as soon as possible. Due to the specialized nature of federal drug injury cases, the Drug Risk Resource Center only recommends lawyers who are already handling Pradaxa lawsuits.
For more information on the research, side effects and litigation news related to Pradaxa and other drugs, or to speak with a lawyer, visit http://www.DrugRisk.com.
***Instutute for Safe Medication Practices, 1/9/13; ismp.org/quarterwatch/pdfs/2012Q2.pdf
****http://www.ilsd.uscourts.gov/mdl/mdl2385.aspx; upcoming events.